Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $12.80 USD
Change Today -1.16 / -8.31%
Volume 687.9K
ZGNX On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Stephen J. Farr Ph.D.

Co-Founder, Chief Executive Officer, President and Director, Zogenix, Inc.
AgeTotal Calculated CompensationThis person is connected to 42 board members in 4 different organizations across 4 different industries.

See Board Relationships
56$1,360,869
As of Fiscal Year 2014

Background*

Dr. Stephen J. Farr, also known as Steve, Ph.D. Co-founded Zogenix, Inc. in 2006 and has been its President since May 2006 and its Chief Executive Officer since April 2015. Dr. Farr served as the Chief Operating Officer at Zogenix, Inc. from August 2006 to March 2013. From 1995 to August 2006, he held positions of increasing responsibility within pharmaceutical sciences and research and development at Aradigm Corporation. He served as the Chief Scientific Officer and ...

Read Full Background

Corporate Headquarters*

12400 High Bluff Drive
San Diego, California 92130

United States

Phone: 858-259-1165
Fax: 858-259-1166

Board Members Memberships*

Director
2006-Present
Co-Founder, Chief Executive Officer, President and Director
2012-Present
Director, Member of Compensation Committee and Member of Audit Committee

Education*

BS
De Montfort University
PhD
University of Wales

Other Affiliations*

Annual Compensation*

Salary$387,544
Total Annual Compensation$387,544

Stock Options*

Exercisable Options1,159,480
Unexercisable Options845,520
Total Number of Options2,005,000

Total Compensation*

Total Annual Cash Compensation$587,544
Total Short Term Compensation$387,544
Total Calculated Compensation$1,360,869
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ZGNX:US $12.80 USD -1.16

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
$470.4K
Howard W. Robin Chief Executive Officer, President and Director
Nektar Therapeutics
$860.0K
Mark A. Sirgo Pharm.D.Chief Executive Officer, President, Chief Scientific Officer, Executive Director and Member of Executive Subcommittee
BioDelivery Sciences International, Inc.
$751.4K
Peter D. Staple Chief Executive Officer, President and Director
Corium International, Inc.
$582.3K
Robert S. Radie Chief Executive Officer, President and Director
Egalet Corporation
$542.4K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZOGENIX INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.